This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Seecure Taiwan Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Hsin-Jou Li: Innovator in Pharmaceutical Development
Hsin-Jou Li is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hepatitis. His innovative work has led to the development of a unique drug conjugate that targets hepatitis viruses.
Latest Patents
Hsin-Jou Li holds 1 patent for a drug conjugate, pharmaceutical composition, and method of treating hepatitis. The patent describes a drug conjugate that includes a structure represented by the formula: Z-(linker-[R]). In this formula, Z represents a drug compound, R is a sugar, and m and n are independently integers ranging from 1 to 6. The drug compound Z is designed to target hepatitis viruses, including hepatitis B virus (HBV), and functions as an inhibitor of apoptosis protein (IAP) antagonist, a multidrug resistance (MDR) inhibitor, or their analogues, precursors, prodrugs, and derivatives.
Career Highlights
Hsin-Jou Li is currently employed at Seecure Taiwan Co., Ltd. His work at this company has been instrumental in advancing pharmaceutical research and development. His innovative approach to drug design has garnered attention in the scientific community.
Collaborations
Hsin-Jou Li has collaborated with notable colleagues, including Wuu-Jyh Lin and Min-Ching Chung. These collaborations have contributed to the success of his research and the development of effective pharmaceutical solutions.
Conclusion
Hsin-Jou Li is a prominent inventor whose work in drug conjugates has the potential to significantly impact the treatment of hepatitis. His innovative contributions to the pharmaceutical industry highlight the importance of research and collaboration in developing effective medical solutions.